Do you lose sleep at night worrying that your dermatology trial will NOT be recruited on time? You can have the best hand-picked international team on your clinical study while maintaining your flexibility and your safety.

We are experts in the conduct of clinical studies in dermatology, oncology, and infectious diseases. Our extraordinary expertise is the result of the continuous development and fostering of a strong, confident, and target-oriented team.

Hundreds of clinical studies that have been successfully concluded within time and budgetary limits speak in our favor. We will dedicate ourselves to your study too, as if it were our own. You can judge the quality of our work on the basis of an accelerated start-up phase, successful patient recruitment, and an efficient completion phase. Your success is our inspiration.

Worldwide market leader in the therapeutic area of dermatological clinical research!

We cover the entire spectrum of services for a dermatological CRO in pharmaceutical and cosmetics contract research. Thanks to our outstanding network of recognized dermatological study sites and KOLs, we guarantee high patient recruitment numbers all over the world. We are also highly familiar with all photo control procedures and documentation electronics.

Since 2005 proinnovera has been awarded with the conduct of 95 Dermatology studies.

Dermatitis
Psoriasis
Actinic Keratosis
Acne
Irritation/Sensitization
Onychomycosis
Rosacea
Infected Eczema
Hyperhidrosis
Prurigo nodularis
Tinea Pedis
Facial Lipoatrophy
Alopecia
Angiofibroma
Dry Feet
Ichthyosis vulgaris
Skin Repair
Tolerability
Transdermal resorption
Warts
Wounds
  • Dermatitis
  • Psoriasis
  • Actinic Keratosis
  • Acne
  • Irritation/Sensitization
  • Onychomycosis
  • Rosacea
  • Infected Eczema
  • Hyperhidrosis
  • Prurigo nodularis
  • Tinea Pedis
  • Facial Lipoatrophy
  • Alopecia
  • Angiofibroma
  • Dry Feet
  • Ichthyosis vulgaris
  • Skin Repair
  • Tolerability
  • Transdermal resorption
  • Warts
  • Wounds
0
Conducted studies in the indication Dermatitis
0
Conducted studies in the indication Psoriasis
0
Conducted studies in the indication Actinic Keratosis
0
Conducted studies in the indication Acne
0
Conducted studies in the indication Irritation/Sensitization
0
Conducted studies in the indication Onychomycosis
0
Conducted studies in the indication Rosacea
0
Conducted studies in the indication Infected Eczema
0
Conducted studies in the indication Hyperhidrosis
0
Conducted studies in the indication Prurigo nodularis
0
Conducted studies in the indication Tinea Pedis
0
Conducted studies in the indication Facial Lipoatrophy
0
Conducted studies in the indication Alopecia
0
Conducted studies in the indication Angiofibroma
0
Conducted studies in the indication Dry Feet
0
Conducted studies in the indication Ichthyosis vulgaris
0
Conducted studies in the indication Skin Repair
0
Conducted studies in the indication Tolerability
0
Conducted studies in the indication Transdermal resorption
0
Conducted studies in the indication Warts
0
Conducted studies in the indication Wounds

Significant market share in oncological clinical research!

In cancer research and as your oncological CRO we have, in addition to clear expertise, in particular a distinct awareness of the complexity of this type of research. Throughout their careers, our Oncology experts have specialized themselves especially on targeted therapies and immuno-oncology. You will benefit from our experience and our network of oncology experts worldwide by entrusting us to conduct your study in a time- and budget-efficient way and assist you in the collection of valid data.

Since 2005 proinnovera has been awarded with the conduct of 38 Oncology studies.

Breast Cancer
Lymphoma
Gastric Cancer
Gastroesophageal cancer
Lung cancer
Ovarian Cancer
Leukemia
Renal Cell Carcinoma
Bone Metastasis
Hepatocellular Carcinoma
  • Breast Cancer
  • Lymphoma
  • Gastric Cancer
  • Gastroesophageal cancer
  • Lung cancer
  • Ovarian Cancer
  • Leukemia
  • Renal Cell Carcinoma
  • Bone Metastasis
  • Hepatocellular Carcinoma
0
Conducted studies in the indication Breast Cancer
0
Conducted studies in the indication Lymphoma
0
Conducted studies in the indication Gastric Cancer
0
Conducted studies in the indication Gastroesophageal cancer
0
Conducted studies in the indication Lung cancer
0
Conducted studies in the indication Ovarian Cancer
0
Conducted studies in the indication Leukemia
0
Conducted studies in the indication Renal Cell Carcinoma
0
Conducted studies in the indication Bone Metastasis
0
Conducted studies in the indication Hepatocellular Carcinoma

Significant market share in clinical research!

As an expert CRO we know that inflammatory diseases play a significant role in the area of immune and autoimmune diseases, genetically-related disorders, chronic respiratory tract diseases, and numerous additional diseases to which the body reacts with signs of infection. Based on our extensive experience, proinnovera is the ideal partner CRO for your study project on inflammatory diseases.

Since 2005 proinnovera has been awarded with the conduct of 37 studies in Inflammatory Diseases.

Arthritis
Crohn's Disease
Influenza
Ankylosing
Spondylitis
Back Pain
Bacterial Vaginosis
Chlamydia trachomatis
Common Cold
Mycosis
Otitis Media
Pneumonia
Tuberculosis
  • Arthritis
  • Crohn's Disease
  • Influenza
  • Ankylosing
  • Spondylitis
  • Back Pain
  • Bacterial Vaginosis
  • Chlamydia trachomatis
  • Common Cold
  • Mycosis
  • Otitis Media
  • Pneumonia
  • Tuberculosis
0
Conducted studies in the indication Arthritis
0
Conducted studies in the indication Crohn's Disease
0
Conducted studies in the indication Influenza
0
Conducted studies in the indication Ankylosing
0
Conducted studies in the indication Spondylitis
0
Conducted studies in the indication Back Pain
0
Conducted studies in the indication Bacterial Vaginosis
0
Conducted studies in the indication Chlamydia trachomatis
0
Conducted studies in the indication Common Cold
0
Conducted studies in the indication Mycosis
0
Conducted studies in the indication Otitis Media
0
Conducted studies in the indication Pneumonia
0
Conducted studies in the indication Tuberculosis